leadf
logo-loader
viewBraveheart Investment Group

Braveheart Investment Group updates on progress of investee firmPhasefocus Holdings

Braveheart said the investee continued to have a strong sales pipeline for its Livecyte2 instruments and has received orders from customers in Italy, Israel and China

Braveheart Investment Group - Braveheart Investment Group updates on progress of investee Phasefocus Holdings

Braveheart Investment Group PLC (LON:BRH) has issued an update on the operations of its investee company Phasefocus Holdings Limited, in which it owns a 42.67% stake.

The investment group said a switch to online sales meetings and virtual demonstrations for Phasefocus, which develops computational imaging technology, was “proving successful” for its high value instrument, the Phasefocus Virtual Lens.

READ: Braveheart investee company P2F orders equipment to make face masks from 2021

Braveheart also said the investee firm continues to have a strong sales pipeline for its Livecyte2 instruments and has received orders from customers in Italy, Israel and China as well as software and hardware upgrades to existing Livecyte users at universities in York, Manchester and Hull and other locations.

Phasefocus is also seeing “growing demand” for long term service contracts, which it saw as an “excellent opportunity to increase guaranteed revenues” while also providing users with “certainty” to continue operating with regular system updates and servicing, the group added.

Braveheart noted that Phasefocus is now working in collaboration with Manchester University to further enhance its LiveCyte product using Artificial Intelligence based image classification.

Quick facts: Braveheart Investment Group

Price: 57.6 GBX

AIM:BRH
Market: AIM
Market Cap: £20.88 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Braveheart Investment Group Pharm2Farm designs antiviral face mask to kill...

Braveheart Investment Group PLC (LON:BRH) investee company Pharm2Farm's (P2F) Gareth Cave talks to Proactive London about their new antiviral face mask that can kill coronavirus (COVID-19). Cave talks through the technology behind the mask, which is says is much stronger than the standard...

on 26/10/20

2 min read